← Eichor
Study identifier: NCT06104007 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study

Condition: Coronary Artery Disease · In-stent Restenosis  ·  Sponsor: Seoul National University Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

The SFRGENISTA study aims to evaluate the long-term efficacy and safety of a paclitaxel-coated balloon catheter containing shellac and vitamin E excipients (Genoss® DCB) in patients with coronary in-stent restenosis (ISR).

This description comes directly from the study's public registry record.

Talk to the study team

Bon-Kwon Koo, MD, PhD  ·  +82-2-2072-2062  ·  bkkoo@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Bon-Kwon KooSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06104007